These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31790437)

  • 41. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
    Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
    Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 43. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Liu L; Hu Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang YG; Wang P; Wang B; Fu ZJ; Zhao WJ; Yan SL
    PLoS One; 2014; 9(5):e95485. PubMed ID: 24830459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
    Zhong C; Wu JD; Fang MM; Pu LY
    Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Wang Q; Wang G; Liu C; He X
    Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
    Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
    PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
    Cui K; Ou Y; Shen Y; Li S; Sun Z
    Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.
    Wang WM; Xu Y; Yang XR; Wang YH; Sun HX; Fan J
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):346-55. PubMed ID: 21813381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.
    Mizukoshi E; Yamashita T; Arai K; Terashima T; Kitahara M; Nakagawa H; Iida N; Fushimi K; Kaneko S
    Cancer Immunol Immunother; 2016 Jun; 65(6):715-25. PubMed ID: 27083166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Jung HI; Jeong D; Ji S; Ahn TS; Bae SH; Chin S; Chung JC; Kim HC; Lee MS; Baek MJ
    Cancer Res Treat; 2017 Jan; 49(1):246-254. PubMed ID: 27456947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological and Prognostic Roles of the Expression Levels of the Programmed Cell Death-1 Gene in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Yang J; Zhang W; Zhang Z; Song F; Ding M; Zhao X; Wang W; Yang Y
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):641-648. PubMed ID: 32990474
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng Z; Zhou L; Gao S; Yang Z; Yao J; Zheng S
    Int J Med Sci; 2013; 10(6):653-64. PubMed ID: 23569429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat treatment for recurrent hepatocellular carcinoma: is it validated?
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Langenbecks Arch Surg; 2011 Oct; 396(7):1093-100. PubMed ID: 21847622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.